Kidney function study of golcadomide
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests how a new drug, golcadomide, works in people with severe kidney problems compared to those with normal kidneys. It helps see if the drug needs different dosing for patients with kidney issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe kidney disease or are on dialysis.
- You are a healthy adult (male or female) who is not able to have children.
- You are between 18 and 84 years old.
- Your body mass index (BMI) is between 18 and 40.
- You do not have other major medical, immune, or psychiatric conditions that could affect the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called RO7795081 in people with different levels of kidney function, including those with kidney problems and those with normal kidneys. It aims to see how safe the medicine is and how the body processes it, which helps doctors decide safe dosing for people with kidney issues.
This study looks at how different levels of kidney function affect the amount of a medication in the body. It may help doctors decide on the right dose for people with kidney problems.
This trial tests an injectable medicine called GMDTC to help remove extra cadmium (a heavy metal) from the body. It is for people with high cadmium levels and decent kidney function, to see if the drug is safe and effective.
This trial tests a medication called EC5026 in people with and without chronic kidney disease (CKD) to see how the body handles it. It helps understand if dose adjustments are needed for people with impaired kidney function.
This study tests a new investigational drug called GV-100 to see how safe it is and how the body handles it. It is for healthy adults and will be given in different doses to find the best one.
This trial tests an investigational medicine called elecoglipron for people with chronic kidney disease. It aims to see if it can improve kidney health compared to a placebo (inactive pill) and may be an option for those already on standard blood pressure and kidney protective medications.
Hear when a new Kidney Failure, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.